A phase II multi-arm study of magrolimab combinations in patients with relapsed/refractory multiple myeloma.
Paul B, Liedtke M, Khouri J, Rifkin R, Gandhi MD, Kin A, Levy MY, Silbermann R, Cottini F, Sborov DW, Sandhu I, Villarreal L, Murphy M, Gu L, Chen A, Rajakumaraswamy N, Usmani SZ.
Paul B, et al. Among authors: kin a.
Future Oncol. 2023 Jan;19(1):7-17. doi: 10.2217/fon-2022-0975. Epub 2023 Feb 13.
Future Oncol. 2023.
PMID: 36779512
Free PMC article.